Aspire Private Capital’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$11 | – | 308 |
|
|
2024
Q3 | $11 | Hold |
1
| – | – | ﹤0.01% | 677 |
|
|
2024
Q2 | $18 | Hold |
1
| – | – | ﹤0.01% | 689 |
|
|
2024
Q1 | $24 | Hold |
1
| – | – | ﹤0.01% | 716 |
|
|
2023
Q4 | $17 | Hold |
1
| – | – | ﹤0.01% | 701 |
|
|
2023
Q3 | $21 | Hold |
1
| – | – | ﹤0.01% | 700 |
|
|
2023
Q2 | $23 | Hold |
1
| – | – | ﹤0.01% | 672 |
|
|
2023
Q1 | $34 | Hold |
1
| – | – | ﹤0.01% | 650 |
|
|
2022
Q4 | $32 | Buy |
+1
| New | +$32 | ﹤0.01% | 647 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 626 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 616 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 618 |
|
|
2021
Q4 | – | Hold |
0
| – | -$1K | – | 645 |
|
|
2021
Q3 | – | Hold |
0
| – | -$2K | – | 542 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 485 |
|